Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cellect Biotechnology Ltd. (APOP)

2.25   0.07 (3.21%) 09-29 09:50
Open: 2.18 Pre. Close: 2.18
High: 2.25 Low: 2.16
Volume: 2,138 Market Cap: 3M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.253 - 2.267 2.267 - 2.277
Low: 2.117 - 2.134 2.134 - 2.147
Close: 2.157 - 2.183 2.183 - 2.2

Technical analysis

as of: 2020-09-28 4:29:51 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.15     One year: 3.78
Support: Support1: 1.81    Support2: 1.51
Resistance: Resistance1: 2.69    Resistance2: 3.24
Pivot: 2.16
Moving Average: MA(5): 2.24     MA(20): 2.14
MA(100): 2.90     MA(250): 2.56
MACD: MACD(12,26): -0.11     Signal(9): -0.16
Stochastic oscillator: %K(14,3): 34.56     %D(3): 46.84
RSI: RSI(14): 44.11
52-week: High: 6.89  Low: 0.40  Change(%): -7.2
Average Vol(K): 3-Month: 15830  10-Days: 38058

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
APOP has closed below upper band by 45.2%. Bollinger Bands are 34.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 25 Sep 2020
Investor Confidence is Rising for Cellect Biotechnology Ltd. (NASDAQ:APOP) - The Oracle Dispatch

Thu, 24 Sep 2020
Cellect Biotechnology Ltd - ADR (APOP) Stock: How Does it Score? - InvestorsObserver

Mon, 21 Sep 2020
Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa - GlobeNewswire

Wed, 12 Aug 2020
Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue Catalysts - PRNewswire

Thu, 06 Aug 2020
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation - PRNewswire

Thu, 21 May 2020
Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19 - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 4
Shares Float (M) 3
% Held by Insiders 9.32
% Held by Institutions 25.19
Shares Short (K) 29
Shares Short P. Month (K) 21

Stock Financials

EPS -0.854
EPS Est This Year -1.560
EPS Est Next Year -1.350
Book Value (p.s.) 0.690
Profit Margin
Operating Margin
Return on Assets (ttm) -37.8
Return on Equity (ttm) -101.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -2.55
PEG Ratio
Price to Book value 3.16
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.